Biochemistry Quiz: Metabolic Disorders And Pathway Defects
20 questions · exam conditions
0:00
Metabolic Disorders And Pathway DefectsQuestion 1 of 20

In the insulin-deficient state of Type 1 diabetes, the metabolic actions of glucagon become unopposed. Which of the following hepatic processes is a direct consequence of this unopposed glucagon signaling?

Suppression of carnitine palmitoyltransferase I (CPT1), leading to potent inhibition of ketogenesis.
Marked stimulation of fatty acid synthesis and subsequent VLDL packaging and export.
Persistent phosphorylation and activation of glycogen phosphorylase and inactivation of glycogen synthase.
Increased transcription of glucokinase to trap any incoming glucose within the hepatocyte.
← Back to quizzes

Biochemistry Quiz

Biochemistry Quiz: Metabolic Disorders And Pathway Defects

Practice Metabolic Disorders And Pathway Defects in Biochemistry with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Metabolic Disorders And Pathway Defects, giving you a quick way to practice the rules, question types, and explanations that matter most for Biochemistry.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

In the insulin-deficient state of Type 1 diabetes, the metabolic actions of glucagon become unopposed. Which of the following hepatic processes is a direct consequence of this unopposed glucagon signaling?

  1. Suppression of carnitine palmitoyltransferase I (CPT1), leading to potent inhibition of ketogenesis.
  2. Marked stimulation of fatty acid synthesis and subsequent VLDL packaging and export.
  3. Persistent phosphorylation and activation of glycogen phosphorylase and inactivation of glycogen synthase. (correct answer)
  4. Increased transcription of glucokinase to trap any incoming glucose within the hepatocyte.
Explanation: When you encounter questions about Type 1 diabetes and glucagon signaling, focus on understanding how insulin normally counterbalances glucagon's effects. In healthy individuals, insulin opposes glucagon's actions, but in insulin-deficient states, glucagon's metabolic effects become dominant and persistent. Glucagon's primary hepatic action involves activating protein kinase A (PKA) through the cAMP pathway. PKA then phosphorylates key regulatory enzymes in glycogen metabolism. Specifically, it phosphorylates and activates glycogen phosphorylase (promoting glycogen breakdown) while simultaneously phosphorylating and inactivating glycogen synthase (preventing glycogen synthesis). Without insulin to counteract this signaling, these enzymes remain in their glucagon-favored states, leading to persistent glycogenolysis. This explains why answer C is correct. Answer A is backwards - glucagon actually relieves CPT1 inhibition by reducing malonyl-CoA levels, thereby promoting ketogenesis, not suppressing it. Answer B contradicts glucagon's metabolic role; glucagon inhibits fatty acid synthesis and promotes fatty acid oxidation instead. The hormone shifts the liver toward catabolic rather than anabolic lipid metabolism. Answer D misrepresents glucagon's glucose-handling strategy - glucagon actually decreases glucokinase expression since its goal is to release glucose from the liver, not trap it within hepatocytes. Remember this pattern: glucagon promotes breakdown pathways (glycogenolysis, gluconeogenesis, fatty acid oxidation) while inhibiting synthesis pathways (glycogenesis, lipogenesis). In Type 1 diabetes, these effects become unopposed and excessive, leading to hyperglycemia and ketosis.

Question 2

A patient with glycogen storage disease type I (von Gierke disease) presents with hepatomegaly and fasting hypoglycemia. A muscle biopsy shows normal glycogen phosphorylase activity. Which biochemical explanation best accounts for the selective hepatic symptoms?

  1. Liver-specific glucokinase deficiency impairs glucose sensing and glycogen metabolism regulation
  2. Hepatic glycogen synthase deficiency prevents glycogen storage in liver while muscle glycogen synthesis remains intact
  3. Tissue-specific expression of glucose-6-phosphatase isoforms creates differential sensitivity to the enzymatic defect
  4. Glucose-6-phosphatase deficiency prevents glucose release from liver glycogen but allows muscle glycogen to fuel local metabolism (correct answer)
Explanation: When you encounter glycogen storage diseases, focus on understanding which tissues are affected and why. The key is recognizing that different tissues use glycogen for different purposes and have different metabolic needs. Von Gierke disease results from glucose-6-phosphatase deficiency, which is crucial for the final step of gluconeogenesis and glycogenolysis. This enzyme converts glucose-6-phosphate to free glucose, allowing glucose to exit cells and enter the bloodstream. The liver's primary role is to maintain blood glucose levels during fasting by releasing glucose from glycogen breakdown. Without glucose-6-phosphatase, the liver cannot release glucose despite having normal glycogen stores and normal phosphorylase activity to break down glycogen to glucose-6-phosphate. This explains the hepatomegaly (enlarged liver full of glycogen) and fasting hypoglycemia (inability to release glucose). Muscle tissue, however, uses glucose-6-phosphate directly for its own energy needs through glycolysis. Muscle doesn't need to release free glucose into circulation, so the glucose-6-phosphatase deficiency doesn't impair muscle function. This is why muscle glycogen phosphorylase activity remains normal and muscle symptoms are minimal. Option A incorrectly identifies glucokinase as the problem. Option B suggests glycogen synthase deficiency, but patients actually have excess glycogen storage, not deficiency. Option C mentions isoforms, but the issue isn't differential sensitivity—it's the functional requirement difference between tissues. Remember: in glycogen storage diseases, always consider what each tissue needs to do with glucose and which enzymes are required for those specific functions.

Question 3

The severe neurological damage associated with untreated phenylketonuria (PKU) is complex. Which of the following is considered a primary biochemical mechanism contributing to this damage?

  1. The byproduct phenylpyruvate acts as a potent neurotoxin by directly uncoupling oxidative phosphorylation in neurons.
  2. High levels of phenylalanine competitively inhibit the transport of other large neutral amino acids into the brain. (correct answer)
  3. The lack of dietary phenylalanine prevents the synthesis of essential myelin proteins required for nerve insulation.
  4. Accumulated phenylalanine is mistakenly incorporated into proteins in place of tyrosine, leading to widespread protein misfolding.
Explanation: When you encounter questions about metabolic disorders like PKU, focus on understanding the specific enzyme deficiency and its downstream consequences rather than getting distracted by complex-sounding mechanisms. PKU results from deficiency in phenylalanine hydroxylase, which normally converts phenylalanine to tyrosine. This leads to massive accumulation of phenylalanine in blood and tissues. The primary mechanism of neurological damage involves the blood-brain barrier's amino acid transport system. Large neutral amino acids (phenylalanine, tyrosine, tryptophan, and others) compete for the same transporter to enter the brain. When phenylalanine levels are extremely elevated, it outcompetes other essential amino acids, preventing them from reaching brain tissue where they're needed for neurotransmitter synthesis and normal brain development. Choice A incorrectly suggests phenylpyruvate directly uncouples oxidative phosphorylation. While phenylpyruvate does accumulate as a byproduct, this isn't the primary mechanism of brain damage. Choice C gets the relationship backward—PKU patients need to restrict, not increase, phenylalanine intake, and the problem isn't lack of dietary phenylalanine. Choice D describes protein misincorporation, but phenylalanine and tyrosine are distinct amino acids with different codons, so this substitution doesn't occur during protein synthesis. The correct answer is B because competitive inhibition of amino acid transport explains why PKU patients develop intellectual disability despite having adequate nutrition otherwise—their brains are essentially starved of crucial amino acids needed for normal development. Remember: metabolic disorder questions often test transport and competition mechanisms, not just the primary enzyme deficiency.

Question 4

A patient is diagnosed with a genetic deficiency of hepatic fructose-1,6-bisphosphatase. This patient would be most susceptible to which metabolic emergency, particularly after a prolonged period without food?

  1. Respiratory alkalosis due to the over-excretion of acidic ketone bodies produced by fatty acid oxidation.
  2. Lactic acidosis because the Cori cycle is blocked, but the TCA cycle continues to function normally.
  3. Hyperglycemia resulting from the shunting of glycolytic intermediates into glycogen synthesis.
  4. Severe hypoglycemia due to an inability to synthesize glucose from non-carbohydrate precursors. (correct answer)
Explanation: When you encounter enzyme deficiency questions, focus on the specific metabolic pathway that's disrupted and trace the downstream consequences. Fructose-1,6-bisphosphatase is a key regulatory enzyme in gluconeogenesis, catalyzing the conversion of fructose-1,6-bisphosphate to fructose-6-phosphate. This is one of the irreversible steps that allows the body to synthesize glucose from non-carbohydrate precursors like lactate, amino acids, and glycerol. During fasting states, when glycogen stores become depleted, gluconeogenesis becomes essential for maintaining blood glucose levels, especially for glucose-dependent tissues like the brain and red blood cells. Without functional fructose-1,6-bisphosphatase, the gluconeogenic pathway is blocked, preventing glucose synthesis from these alternative sources. During prolonged fasting, this leads to severe hypoglycemia as the body cannot compensate for falling blood glucose levels, making answer D correct. Answer A is incorrect because ketone body production actually helps prevent acidosis during normal fasting - they're not "over-excreted" and don't cause respiratory alkalosis. Answer B misunderstands the Cori cycle; while lactate recycling to glucose would be impaired, this doesn't specifically cause lactic acidosis through continued TCA cycle function. Answer C contradicts the actual consequence - without gluconeogenesis, glycolytic intermediates cannot be effectively converted to glucose, and glycogen synthesis requires glucose as a substrate. Remember: enzyme deficiencies in gluconeogenesis always think "fasting hypoglycemia." The body's backup glucose production system fails when dietary glucose and glycogen stores are insufficient.

Question 5

The measurement of glycated hemoglobin (HbA1c) is a standard tool for monitoring long-term glycemic control. The biochemical basis for its utility is that:

  1. hemoglobin is glycated by fructose-derived metabolites, and its level reflects the patient's long-term sugar and fructose intake.
  2. an enzyme, hemoglobin glycase, is upregulated by insulin and its activity reflects the average insulin signaling over several months.
  3. the binding of glucose to hemoglobin permanently increases its oxygen affinity, providing a measurable index of chronic hyperglycemia.
  4. the non-enzymatic glycation of hemoglobin is proportional to the average blood glucose concentration over the lifespan of an erythrocyte. (correct answer)
Explanation: When you encounter questions about HbA1c, focus on the fundamental biochemistry: non-enzymatic glycation and red blood cell lifespan. HbA1c reflects chronic glucose exposure because glucose spontaneously reacts with amino groups on hemoglobin through a non-enzymatic process called glycation. This reaction occurs continuously throughout the 120-day lifespan of red blood cells, and the amount of glycated hemoglobin formed is directly proportional to the average glucose concentration the cells encounter. Option D correctly captures this mechanism. The key insight is that this glycation is irreversible and accumulates over time, making HbA1c a reliable indicator of average blood glucose over 2-3 months (the typical red blood cell lifespan). Option A is incorrect because HbA1c primarily reflects glucose, not fructose metabolism. While fructose can contribute to glycation, glucose is the dominant sugar involved in HbA1c formation. Option B incorrectly describes an enzymatic process. There's no such enzyme as "hemoglobin glycase" involved in HbA1c formation. The glycation is non-enzymatic and occurs spontaneously when glucose concentrations are elevated. Option C misrepresents the functional consequence. While glycation does slightly alter hemoglobin's oxygen affinity, this isn't the basis for its clinical utility. The measurement relies on detecting the glycated hemoglobin itself, not changes in oxygen binding. Remember: HbA1c questions test your understanding of non-enzymatic glycation as a time-integrated measure of glucose exposure. The "non-enzymatic" aspect and the connection to red blood cell lifespan are crucial concepts that frequently appear on biochemistry exams.

Question 6

A 19-year-old is brought to the emergency department with confusion, rapid breathing, and dehydration. Lab tests reveal a blood glucose of 550 mg/dL, arterial pH of 7.15, and high levels of β-hydroxybutyrate. The patient's serum C-peptide level is found to be undetectable.

Based on these findings, which statement provides the most accurate biochemical explanation for this patient's condition?

  1. An absolute deficiency of insulin has led to uncontrolled gluconeogenesis and ketogenesis, consistent with Type 1 diabetes. (correct answer)
  2. Severe insulin resistance has impaired glucose uptake, but enough insulin is present to suppress ketosis, consistent with Type 2 diabetes.
  3. The patient's symptoms are due to renal failure, where impaired glucose filtration and acid excretion mimic a diabetic state.
  4. A defect in a gluconeogenic enzyme is causing a buildup of glucose precursors that are subsequently converted to ketones.
Explanation: The correct answer is A. The patient presents with the classic triad of diabetic ketoacidosis (DKA): hyperglycemia (550 mg/dL), acidosis (pH 7.15), and ketosis (high β-hydroxybutyrate). The key diagnostic clue is the undetectable C-peptide level. C-peptide is cleaved from proinsulin when insulin is produced. An undetectable level indicates the pancreatic β-cells are not producing insulin, which is the hallmark of Type 1 diabetes. B is incorrect because the presence of severe ketosis is inconsistent with the typical presentation of Type 2 diabetes, where some residual insulin is usually sufficient to suppress unrestrained ketogenesis. Also, the C-peptide would likely be normal or high in early T2D. C is incorrect because while renal function is affected in DKA, the underlying cause is metabolic, not renal failure. D is incorrect because a defect in a gluconeogenic enzyme would lead to hypoglycemia, not the severe hyperglycemia observed.

Question 7

A dietary plan for a child with phenylketonuria (PKU) severely restricts phenylalanine intake but does not eliminate it entirely. What is the most critical biochemical reason for including a minimal amount of phenylalanine in the diet?

  1. Phenylalanine is an essential amino acid and is required as a building block for the synthesis of all cellular proteins. (correct answer)
  2. A small amount of phenylalanine is necessary to allosterically activate the residual function of the defective hydroxylase enzyme.
  3. Complete removal of phenylalanine would cause a toxic accumulation of its metabolic precursors, such as chorismate.
  4. The body requires a low level of phenylalanine to maintain the production of phenylacetate for proper renal function.
Explanation: The correct answer is A. Phenylalanine is one of the essential amino acids, meaning humans cannot synthesize it and must obtain it from their diet. It is a necessary component for the synthesis of all proteins. Therefore, while intake must be restricted to prevent its accumulation to toxic levels in PKU patients, it cannot be completely eliminated without causing a different form of malnutrition and halting protein synthesis. B is incorrect; substrate concentration would not activate a genetically deficient enzyme in this manner. C is incorrect as chorismate is a precursor in the synthesis pathway of aromatic amino acids in plants and bacteria, not a precursor that would accumulate in humans. D is incorrect because phenylacetate is a toxic byproduct of excess phenylalanine and is not required for renal function.

Question 8

While severe ketoacidosis is a hallmark of untreated Type 1 diabetes, it is relatively uncommon in patients with Type 2 diabetes. What is the most plausible biochemical explanation for this difference?

  1. In Type 2 diabetes, circulating insulin, though insufficient for euglycemia, is adequate to suppress hormone-sensitive lipase. (correct answer)
  2. Hepatocytes in Type 2 diabetics develop resistance to glucagon's ketogenic signals in parallel with their insulin resistance.
  3. The extreme hyperglycemia in Type 2 diabetes allosterically inhibits the carnitine shuttle, preventing fatty acid oxidation.
  4. Peripheral tissues in Type 2 diabetics have a greatly enhanced capacity for ketone body utilization compared to those in Type 1.
Explanation: The correct answer is A. The development of DKA requires near-total lack of insulin's effects. One of insulin's most sensitive actions is the suppression of hormone-sensitive lipase in adipose tissue. In Type 2 diabetes, there is insulin resistance, but patients still produce some endogenous insulin. This small amount is often sufficient to prevent the runaway lipolysis that provides the massive fatty acid substrate load for ketogenesis in the liver. Thus, while hyperglycemia can be severe, ketogenesis is held in check. B is incorrect; there is no evidence that glucagon resistance develops in this specific manner. C is incorrect; malonyl-CoA (from fatty acid synthesis) inhibits the carnitine shuttle, but fatty acid synthesis is low in the diabetic state, and glucose itself does not have this effect. D is incorrect; there is no significant difference in the capacity for ketone body utilization between the two types.

Question 9

Metformin is a common oral medication for Type 2 diabetes. Its primary cellular target is the activation of AMP-activated protein kinase (AMPK). This activation therapeutically benefits the patient primarily by:

  1. stimulating the release of pre-synthesized insulin from storage vesicles in pancreatic β-cells.
  2. inhibiting transcriptional expression of key gluconeogenic enzymes in the liver, thus reducing hepatic glucose output. (correct answer)
  3. potentiating the signaling cascade of glucagon, leading to more efficient glycogenolysis in the fed state.
  4. blocking the action of the GLUT4 transporter at the muscle cell surface, preventing glucose-induced toxicity.
Explanation: When you encounter questions about diabetes medications and their mechanisms, focus on understanding how different drugs target distinct pathways in glucose homeostasis. Metformin's mechanism centers on AMPK activation, which acts as a cellular energy sensor. AMPK activation by metformin primarily reduces hepatic glucose production through transcriptional regulation. When AMPK is activated, it phosphorylates and inactivates key transcription factors like CREB and ChREBP, which normally promote expression of gluconeogenic enzymes such as PEPCK and G6Pase. This transcriptional suppression means the liver produces less glucose, directly addressing the elevated blood glucose characteristic of Type 2 diabetes. Option A is incorrect because metformin doesn't target pancreatic β-cells or insulin release mechanisms - that's the mechanism of sulfonylureas like glyburide. Option C misrepresents both metformin's target and physiological logic, as glucagon promotes glucose production (the opposite of what's therapeutic), and efficient glycogenolysis in the fed state would be counterproductive. Option D contradicts metformin's actual effect - AMPK activation actually enhances GLUT4 translocation to increase glucose uptake, and blocking glucose transport would worsen hyperglycemia rather than treat it. The key study strategy for diabetes pharmacology is to categorize medications by their primary targets: β-cell insulin release (sulfonylureas), insulin sensitivity (thiazolidinediones), glucose absorption (α-glucosidase inhibitors), or hepatic glucose production (metformin). Understanding that metformin uniquely targets the liver's glucose output through AMPK will help you recognize its mechanism among distractors.

Question 10

An infant with untreated PKU may have urine with a characteristic 'musty' odor. This is caused by the accumulation and excretion of metabolites from a minor pathway that becomes significant when phenylalanine levels are pathologically high. Which of the following is one of these diagnostic metabolites?

  1. α-Ketoisocaproate
  2. Homogentisate
  3. Phenylacetate (correct answer)
  4. Tyramine
Explanation: When you encounter questions about metabolic disorders like PKU (phenylketonuria), focus on understanding how enzyme deficiencies create metabolic bottlenecks that redirect substrates into alternative pathways. In PKU, phenylalanine hydroxylase is deficient, preventing the normal conversion of phenylalanine to tyrosine. When phenylalanine accumulates to pathologically high levels, it overwhelms the primary metabolic pathway and gets shunted into normally minor alternative routes. One such pathway involves transamination of phenylalanine to phenylpyruvate, which is then metabolized through several steps including decarboxylation and reduction, ultimately producing phenylacetate. This compound, along with phenylpyruvate itself, gives PKU patients' urine its characteristic musty odor and serves as a diagnostic marker. Choice C (phenylacetate) is correct because it's directly derived from the alternative metabolism of accumulated phenylalanine in PKU patients. Choice A (α-ketoisocaproate) is wrong—this is a metabolite of leucine, not phenylalanine, and is associated with maple syrup urine disease. Choice B (homogentisate) is incorrect because it's an intermediate in tyrosine metabolism that accumulates in alkaptonuria, not PKU. Choice D (tyramine) is wrong since PKU actually results in decreased tyrosine production, not increased tyramine formation. Remember that in metabolic disorder questions, the key is tracing the metabolic consequences of specific enzyme deficiencies. When the normal pathway is blocked, substrates accumulate and flow into alternative routes, creating characteristic metabolic signatures that become diagnostic tools.

Question 11

A patient with diabetes mellitus shows persistently elevated HbA1c levels (9.2%; normal <7%) despite reported good glucose control. Laboratory analysis reveals average blood glucose of 180 mg/dL over the past 3 months. Which molecular mechanism best explains the HbA1c elevation?

  1. Enzymatic glycosylation of hemoglobin β-chains occurs proportionally to glucose concentration through hexokinase-mediated phosphorylation
  2. Non-enzymatic glycation of hemoglobin amino groups occurs proportionally to glucose concentration and reflects long-term glycemic control (correct answer)
  3. Oxidative modification of hemoglobin iron centers by glucose metabolites creates stable adducts measured as HbA1c
  4. Competitive inhibition of hemoglobin oxygen binding by glucose creates conformational changes detected as glycated hemoglobin
Explanation: HbA1c formation involves non-enzymatic glycation (not glycosylation) of amino groups on hemoglobin, primarily the N-terminal valine of β-globin chains. This process is directly proportional to glucose concentration and time, making it an excellent marker of average glycemic control over the lifespan of red blood cells (120 days). Choice A incorrectly describes enzymatic phosphorylation. Choice C incorrectly focuses on iron oxidation rather than amino group modification. Choice D incorrectly suggests competitive inhibition affecting oxygen binding.

Question 12

A newborn screening program identifies an infant with elevated methionine and decreased cysteine levels. Further testing reveals homocystinuria. If left untreated, which metabolic consequence would most likely develop due to this enzymatic defect?

  1. Defective collagen cross-linking due to inadequate cysteine availability for disulfide bond formation in structural proteins
  2. Impaired methylation reactions due to S-adenosylmethionine depletion from blocked homocysteine metabolism
  3. Toxic accumulation of methionine metabolites leading to hepatic dysfunction and altered protein synthesis
  4. Reduced glutathione synthesis due to cysteine deficiency, leading to oxidative stress and cellular damage (correct answer)
Explanation: Homocystinuria typically results from cystathionine β-synthase deficiency, blocking the conversion of homocysteine to cystathionine and subsequently to cysteine. Cysteine is essential for glutathione synthesis, and its deficiency leads to reduced antioxidant capacity and oxidative stress. This contributes to the vascular and connective tissue problems seen in homocystinuria. Choice A confuses cysteine's role in glutathione vs. structural proteins. Choice B is incorrect because SAM levels are typically elevated, not depleted. Choice C doesn't reflect the primary pathophysiology of cysteine deficiency.

Question 13

A patient with type 1 diabetes experiences a hypoglycemic episode after insulin injection. Emergency glucose administration rapidly restores consciousness. Which metabolic transition best explains the immediate biochemical response to glucose administration in this patient?

  1. Activation of glycogen synthase through dephosphorylation while simultaneously inhibiting glycogen phosphorylase through phosphorylation (correct answer)
  2. Stimulation of gluconeogenesis to rapidly increase glucose production from amino acid precursors in the liver
  3. Enhanced fatty acid oxidation to provide alternative fuel sources while sparing glucose for neural tissue
  4. Immediate activation of the pentose phosphate pathway to generate NADPH for biosynthetic reactions
Explanation: Glucose administration triggers insulin release, which activates protein phosphatase-1, leading to dephosphorylation and activation of glycogen synthase while simultaneously inactivating glycogen phosphorylase. This rapidly shifts from glycogen breakdown to glycogen synthesis. Choice B is incorrect because gluconeogenesis would be inhibited, not stimulated, by glucose/insulin. Choice C describes the fasting state response, opposite to glucose administration. Choice D, while the PPP is important, is not the immediate priority during hypoglycemia recovery.

Question 14

A research study examines three patients with different metabolic disorders: Patient A: Elevated phenylalanine, decreased tyrosine, intellectual disability Patient B: Hyperglycemia, polyuria, ketosis during fasting Patient C: Hypoglycemia during fasting, normal fed-state glucose levels

Based on the clinical profiles described in the passage above, which combination of primary enzymatic defects best matches patients A, B, and C respectively?

  1. Phenylalanine hydroxylase deficiency, insulin receptor defects, glucose-6-phosphatase deficiency
  2. Tyrosinase deficiency, pancreatic β-cell destruction, glycogen phosphorylase deficiency
  3. Phenylalanine hydroxylase deficiency, pancreatic β-cell destruction, glucose-6-phosphatase deficiency (correct answer)
  4. Branched-chain amino acid transaminase deficiency, insulin receptor defects, glycogen synthase deficiency
Explanation: Patient A shows classic PKU (phenylalanine hydroxylase deficiency). Patient B shows type 1 diabetes characteristics (β-cell destruction leading to insulin deficiency). Patient C shows fasting hypoglycemia with normal fed-state glucose, consistent with glucose-6-phosphatase deficiency (von Gierke disease) where glycogenolysis is impaired but glycogen synthesis works normally. Choice A incorrectly suggests insulin receptor defects for type 1 diabetes. Choice B misidentifies PKU as tyrosinase deficiency (albinism) and suggests glycogen phosphorylase deficiency (which would cause exercise intolerance, not fasting hypoglycemia). Choice D incorrectly identifies maple syrup urine disease instead of PKU.

Question 15

A patient with uncontrolled type 2 diabetes presents with blood glucose of 450 mg/dL and elevated ketones. Despite hyperglycemia, gluconeogenesis remains active. Which regulatory mechanism best explains this paradoxical continued glucose production?

  1. Insulin resistance prevents glucose uptake by peripheral tissues, creating a cellular starvation signal that maintains gluconeogenesis (correct answer)
  2. High glucose concentrations saturate glucokinase, eliminating glucose sensing in hepatocytes and removing feedback inhibition
  3. Elevated glucagon-to-insulin ratio maintains phosphorylation of acetyl-CoA carboxylase, promoting gluconeogenic enzyme expression
  4. Ketone body production creates an alternative carbon source that drives the gluconeogenic pathway through substrate availability
Explanation: In insulin resistance with relative insulin deficiency, peripheral tissues cannot effectively uptake glucose despite hyperglycemia. This creates a paradoxical 'cellular starvation' state where gluconeogenesis continues because the liver responds to the perceived need for glucose production. Choice B is incorrect because glucokinase is not easily saturated and glucose sensing would still function. Choice C confuses the role of ACC (fatty acid synthesis regulation) with gluconeogenesis. Choice D incorrectly suggests ketones drive gluconeogenesis rather than being an alternative fuel that spares glucose.

Question 16

A patient with poorly controlled diabetes develops diabetic nephropathy. Biochemical analysis shows increased advanced glycation end products (AGEs) in renal tissue. Which molecular mechanism best explains how hyperglycemia leads to AGE formation and subsequent tissue damage?

  1. Glucose directly binds to DNA bases causing mutations that alter protein expression profiles in renal cells
  2. Non-enzymatic glycation of amino groups progresses through oxidative rearrangements to form irreversible cross-linked protein adducts (correct answer)
  3. Glucose competitively inhibits antioxidant enzymes, leading to increased reactive oxygen species and protein carbonylation
  4. Hyperglycemia activates protein kinase C, which phosphorylates extracellular matrix proteins causing abnormal cross-linking
Explanation: AGE formation begins with non-enzymatic glycation of amino groups on proteins (forming Schiff bases), which rearrange to more stable Amadori products, then undergo further oxidative modifications to form irreversible, cross-linked AGEs. These AGEs accumulate in long-lived proteins like collagen, causing tissue dysfunction. Choice A incorrectly focuses on DNA rather than protein modification. Choice C describes oxidative stress but not the specific glycation mechanism. Choice D incorrectly describes PKC-mediated phosphorylation rather than glycation chemistry.

Question 17

An infant with PKU maintained on a phenylalanine-restricted diet develops cataracts and intellectual disability despite normal phenylalanine levels. Genetic analysis reveals a deficiency in dihydropteridine reductase rather than phenylalanine hydroxylase. Which biochemical consequence best explains the continued symptoms?

  1. Inability to regenerate tetrahydrofolate cofactor disrupts one-carbon metabolism essential for nucleotide synthesis
  2. Defective regeneration of tetrahydrobiopterin impairs tyrosine and tryptophan hydroxylases, reducing neurotransmitter synthesis (correct answer)
  3. Accumulation of dihydrobiopterin creates competitive inhibition of aromatic amino acid decarboxylase
  4. Loss of cofactor recycling leads to increased phenylalanine hydroxylase degradation and secondary enzyme deficiency
Explanation: Dihydropteridine reductase is essential for regenerating tetrahydrobiopterin (BH4) from dihydrobiopterin. BH4 is required not only for phenylalanine hydroxylase but also for tyrosine hydroxylase (dopamine synthesis) and tryptophan hydroxylase (serotonin synthesis). Without adequate neurotransmitter production, neurological symptoms persist despite normal phenylalanine levels. Choice A confuses BH4 with tetrahydrofolate. Choice C incorrectly suggests competitive inhibition mechanism. Choice D misunderstands that the enzyme itself isn't degraded; rather, cofactor availability is the issue.

Question 18

A 6-month-old infant with phenylketonuria (PKU) has been maintained on a phenylalanine-restricted diet since birth. Despite good dietary compliance, the child shows elevated phenylalanine levels (15 mg/dL; normal <2 mg/dL) and decreased tyrosine levels. Which of the following best explains this metabolic profile?

  1. Complete absence of phenylalanine hydroxylase activity requires elimination of all dietary phenylalanine to prevent toxic accumulation
  2. Residual phenylalanine hydroxylase activity is insufficient to handle even minimal phenylalanine intake required for protein synthesis
  3. Tyrosine becomes conditionally essential because the primary biosynthetic pathway from phenylalanine is impaired (correct answer)
  4. Phenylalanine restriction leads to compensatory upregulation of alternative metabolic pathways that produce toxic metabolites
Explanation: In PKU, phenylalanine hydroxylase deficiency blocks the conversion of phenylalanine to tyrosine. Even with dietary restriction, some phenylalanine is essential for protein synthesis, leading to accumulation when the enzyme is deficient. Tyrosine becomes conditionally essential because the normal biosynthetic pathway is impaired, requiring dietary supplementation. Choice A is incorrect because complete elimination of phenylalanine is impossible and unnecessary. Choice B misses that tyrosine supplementation is the key issue. Choice D incorrectly suggests the problem is from restriction rather than the enzymatic defect.

Question 19

A clinical study compares glucose metabolism in three groups: Group 1: Healthy controls Group 2: Type 1 diabetics on insulin therapy Group 3: Type 2 diabetics with insulin resistance

During a glucose tolerance test, researchers measure hepatic glucose output using isotopic tracers.

Based on the study design described in the passage above, which pattern of hepatic glucose output would be expected 2 hours after glucose administration?

  1. Group 1: suppressed, Group 2: suppressed with insulin, Group 3: incompletely suppressed despite elevated glucose (correct answer)
  2. Group 1: suppressed, Group 2: elevated due to glucagon dominance, Group 3: suppressed due to hyperglycemia feedback
  3. Group 1: unchanged, Group 2: suppressed with insulin, Group 3: elevated due to increased gluconeogenesis
  4. Group 1: suppressed, Group 2: unchanged due to insulin deficiency, Group 3: elevated due to peripheral insulin resistance
Explanation: Group 1 (healthy) should suppress hepatic glucose output normally after glucose load. Group 2 (type 1) should suppress output when adequate insulin is provided through therapy. Group 3 (type 2 with insulin resistance) shows the characteristic problem where hepatic glucose output is incompletely suppressed despite hyperglycemia due to hepatic insulin resistance. Choice B incorrectly suggests Group 2 has glucagon dominance with proper insulin therapy. Choice C incorrectly states healthy individuals don't suppress glucose output. Choice D overstates the degree of dysregulation in Group 2 with adequate insulin therapy.

Question 20

A patient with newly diagnosed, untreated Type 1 diabetes often presents with significant weight loss and muscle wasting. This catabolic state is primarily a consequence of:

  1. accelerated proteolysis in muscle to supply amino acid substrates, such as alanine, for hepatic gluconeogenesis. (correct answer)
  2. the direct conversion of muscle protein into ketone bodies within myocytes to be used as an alternative fuel source.
  3. toxic effects of hyperglycemia that cause non-enzymatic degradation of actin and myosin contractile filaments.
  4. a global shutdown of cellular respiration in muscle cells due to the inability to import sufficient glucose.
Explanation: The correct answer is A. In the insulin-deficient state of T1D, the body enters a catabolic, fasted-like state. The liver is performing high rates of gluconeogenesis to produce glucose that the body cannot effectively use. A major source of carbon skeletons for this process is amino acids derived from the breakdown (proteolysis) of muscle protein. Alanine, in particular, is a key gluconeogenic precursor transported from muscle to the liver (the glucose-alanine cycle). This leads to a negative nitrogen balance, muscle wasting, and weight loss. B is incorrect because ketone bodies are synthesized from fatty acids, and this process occurs in the liver, not muscle. C is incorrect because while glycation of proteins occurs, it is not the primary mechanism of the rapid muscle wasting seen in acute T1D. D is incorrect because muscle cells can switch to using fatty acids as their primary fuel, so respiration does not shut down.